Christopher L. Lotz, Vice President of Finance, CFO at Qualigen Therapeutics, Inc. (QLGN), bought 2,700 shares at $1.86 ($5K) on 2021-04-16, disclosed to the SEC on 2021-04-19.
Open-market purchase of $5k QLGN by Vice President of Finance, CFO. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.